Status of The Health-Related Sdgs
Status of The Health-Related Sdgs
Status of The Health-Related Sdgs
Overview
STATUS OF THE
HEALTH-RELATED
SDGs
Neonatal (0–27 days) Globally, HIV incidence has declined from 0.40 per 1000
Postneonatal (1–59 months)
Under-fives uninfected population in 2005 to 0.26 per 1000 uninfected
Prematurity
Prematurity
population in 2016 (10). The WHO African Region remained
Acute Acute
respiratory infections
respiratory infections the most heavily impacted by HIV, with an incidence rate of
Birth asphyxia and birth trauma
Other
Birth asphyxia
communicable,
Other
and birth trauma
perinataland
communicable, perinatal
1.24 per 1000 uninfected population in 2016 (11). In 2016,
and nutritional conditions
nutritional
Congenital
conditions
anomalies
Congenital anomalies
an estimated 1 million people died of HIV-related illnesses
Diarrhoea
Diarrhoea ¬Neonatal
120 000
(0−27 days) of whom were children under 15 years of age.
Postneonatal
Neonatal sepsis
Neonatal sepsis The global scale-up of antiretroviral therapy (ART) has
(1−59 months)
Injuries
Injuries
Malaria
been the main driver of the 48% decline in HIV-related
Malaria
Other noncommunicable diseases
Other noncommunicable diseases deaths
Under−fives from a peak of 1.9 million in 2005. By mid-2017,
Meningitis/encephalitis
Meningitis/encephalitis approximately 20.9 million people were receiving ART.
Measles
Measles
However, ART only reached 53% of people living with HIV
HIV/AIDS
HIV/AIDS
Tetanus
Tetanus
at the end of 2016, and a rapid acceleration of responses is
0l 5l l
10 l
15 needed to increase treatment coverage, along with other
0 5
Percentage 10
of total under−five deaths 15
Percentage of total under-five deaths
interventions along the continuum of services, including
prevention, diagnosis and chronic care (12).
were people living with HIV. In that same year, there were 1— 1
2—
0—
l l l l l
2000 2004 2008 2012 2016
1
Depending on the year of vaccine introduction, this can range from the 1980s to the early
2000s.
2
The NTDs focused on by WHO are: Buruli ulcer; Chagas disease; dengue and
chikungunya; dracunculiasis (guinea-worm disease); echinococcosis; foodborne
In 2015, an estimated 325 million people worldwide were trematodiases; human African trypanosomiasis (sleeping sickness); leishmaniasis;
leprosy (Hansen’s disease); lymphatic filariasis; mycetoma; chromoblastomycosis
living with hepatitis B virus (HBV) or hepatitis C virus and other deep mycoses; onchocerciasis (river blindness); rabies; scabies and other
(HCV) infection. Such infection carries the risk of slow ectoparasites; schistosomiasis; soil-transmitted helminthiases; snake-bite envenoming;
taeniasis/cysticercosis; trachoma; and yaws (endemic treponematoses). See: http://www.
progression to severe liver disease and death unless timely who.int/neglected_diseases/diseases/en/.
2016 at 9.8 litres of pure alcohol per person aged 15 years 45−54 Mal
45–54
Fem
or older (Fig. 2.5) (19). Available data indicate that treatment 35−44
35–44
coverage for alcohol and drug-use disorders is inadequate, 25−34
25–34
though further work is needed to improve the measurement 15−24
15–24
of such coverage. 5−14
5–14
l
100
l
75
l
50
l
25
l
0
l
25
l
50
l
75
l
100
100 75 50 25 0 25 50 75 100
Fig. 2.5 Number of suicides (thousands)
Number of suicides (thousands)
Trends in alcohol consumption among people aged 15 years or older, by WHO region
and globally, 2010–2016
12 —
10 —
consumption (litres of pure alcohol)
40 —
PCV3 Each year, billions of dollars are spent on research and
30 — development into new or improved health products
20 —
and processes, ranging from medicines to vaccines to
diagnostics. But the way these funds are distributed and
10 —
spent is often poorly aligned with global public health
0—
l l l l needs. Countries with comparable levels of income and
2000 2005 2010 2016
health needs receive different levels of official development
assistance for medical research and for basic health sectors.
stocked medicines for pain management and palliative care. Of grant recipients by income group, low-income countries
Less than 10% of the public-sector health facilities surveyed received only 0.3% of all direct grants (31).
in low-income countries stocked opioid analgesics such as
morphine, buprenorphine, codeine, methadone and tramadol In terms of monitoring health status, WHO estimates
¬ essential medications for treating the pain associated with that about half of its 194 Member States register at least
many advanced progressive conditions (27, 28). 80% of deaths of population aged 15 years and older, with
associated information provided on cause of death (18). In
Latest estimates indicate that in 2016, one in 10 children addition, data-quality problems further limit the use of such
worldwide did not receive even the first dose of diphtheria- information.
tetanus-pertussis (DTP1) vaccine. In the same year, the
global coverage of three doses of DTP (DTP3) vaccine
among children was 86% (Fig. 2.8). As shown in Fig. 2.8, 2.6 Environmental risks
this level has essentially remained unchanged since 2010.
During this same period, coverage of a second dose of Access to clean fuels and technologies for cooking has
measles-containing vaccine (MCV2) increased from 39% marginally improved and in 2016 reached 59% globally ¬
to 64% but this is still insufficient to prevent measles an increase of 10 percentage points since 2000. However,
outbreaks and avoid preventable deaths. Global coverage coverage levels vary greatly between countries (Fig. 2.9)
Fig. 2.9
Proportion of population with primary reliance on clean fuels and technologies (%), 2016
Note: Estimates for India, Israel, Lithuania and Portugal are under country consultation as of May 2018.
Fig. 2.10
Proportion of global population by type of drinking-water services and sanitation
services used, 2015
Drinking
Sanitation
water
Drinking
Sanitation
Water
0l l
20 l
40 l
60 l
80 l
100
Percent
0 20 40 60 80 100
Safely managed Percent Improved
Surface water (Water)
Basic
Open defecation (Sanitation)
Limited
30. WHO/UNICEF estimates of national immunization coverage 34. International Health Regulations (2005) Monitoring Framework
[online database]. July 2017 revision. Geneva: World Health [online database]. Global Health Observatory (GHO) data.
Organization (http://www.who.int/immunization/monitoring_ Geneva: World Health Organization (http://www.who.int/gho/
surveillance/routine/coverage/en/index4.html, accessed 12 April ihr/en/).
2018).
35. States Parties to the International Health Regulations (2005)
31. Global Observatory on Health R&D. One year on, Global [website]. Geneva: World Health Organization (http://www.who.
Observatory on Health R&D identifies striking gaps and int/ihr/legal_issues/states_parties/en/, accessed 24 April 2017).
inequalities (http://www.who.int/features/2018/health-research-
and-development/en/, accessed 12 April 2018).